The balance between benefits and harms of molecular targeted agents.
S. Niraula
No relevant relationships to disclose
E. Amir
No relevant relationships to disclose
A. Ocana
No relevant relationships to disclose
B. Seruga
No relevant relationships to disclose
I. Tannock
No relevant relationships to disclose